ELBOROM contains eltrombopag, a medicine used to help increase the number of platelets in the blood. Platelets are essential for blood clotting, and low levels can lead to serious bleeding problems. ELBOROM is especially useful for patients who have certain blood disorders where platelet levels remain low despite other treatments. It is taken by mouth, usually once daily, and offers an important option for patients whose conditions are difficult to manage with standard therapies.

Mechanism of Action
Eltrombopag works by stimulating the body’s own platelet production. It acts on the thrombopoietin receptor in the bone marrow, encouraging the stem cells to produce more platelets. This process helps reduce the risk of bleeding and may allow patients to avoid or reduce the need for platelet transfusions. The medicine does not replace platelets directly but helps the body make more of its own over time.

Uses

ELBOROM is prescribed in several specific conditions involving low platelet counts, including:

• Chronic immune thrombocytopenia (ITP) in adults and children who have not responded well to other treatments such as corticosteroids or immunoglobulins

• Thrombocytopenia in patients with hepatitis C virus infection, to help enable and maintain interferon-based treatment

• Severe aplastic anemia in adults when other treatments have failed or are not suitable

  Adverse Effects

• ELBOROM is generally well tolerated, but like all medicines, it can cause side effects. Common ones include headache, nausea, fatigue, and elevated liver enzymes. Some patients may also experience pain in the muscles or bones. A small number of people may develop more serious effects such as blood clots, liver problems, or cataracts with long-term use. Liver function tests are usually done regularly during treatment to monitor for any changes.